The phase 3 trial, conducted at the University of Chicago, found that most patients treated with the drug had “rapid recoveries in fever and respiratory symptoms,” according to the original report from STAT News.
根据来自STAT新闻的原始报告，在芝加哥大学进行的第三阶段试验发现，大多数接受该药治疗的患者“发烧和呼吸道症状迅速恢复”。